← Back to news
S

Seeking Alpha: News

Primo Brands forecasts 2026 comparable net sales growth of 2% to 4% while reaffirming $1.465B to $1.515B adjusted EBITDA

S

NRP plans to raise distributions significantly in November as debt falls to $14M

S

Choice Hotels expects 2026 adjusted EBITDA of $635M-$650M as it raises RevPAR and net rooms growth outlook

S

Par Pacific expects Q3 midpoint throughput of 182,000 barrels per day following Hawaii turnaround

S

Kadant forecasts 2026 adjusted EPS of $12.43-$12.68 as it raises revenue outlook to $1.190B-$1.210B

S

Regenxbio Q2 2026 Earnings Preview

S

MFA outlines $26M-$27M quarterly run-rate G&A through 2026 as delinquent loan resolutions accelerate

S

Holley reaffirms 2026 guidance and targets leverage below 3.5x as $12M retailer placements launch in Q3

S

Elanco anticipates 6%-7% organic constant currency growth and ~$3x net leverage by year-end 2026

S

OTP Bank reports Q2 results

S

Disney's parks and pictures keep the magic alive -- analysts

S

GlobalFoundries dips despite Q2 beat

S

Raia Drogasil S.A. reports Q2 results

S

Commerce.com, Inc. Q2 Earnings Preview

S

Howmet Aerospace Q2 2026 Earnings Preview

S

Constellation Energy Q2 2026 Earnings Preview

S

Sabre Q2 2026 Earnings Preview

S

BKV Q2 2026 Earnings Preview

S

Precision BioSciences Q2 2026 Earnings Preview

S

BASE reports 1H results

S

Coca-Cola HBC AG reports 1H results

B

Payoneer Global Q2 2026 Earnings Preview

B

Roivant Sciences Q1 2027 Earnings Preview

B

Northrop, Boeing test AI-enabled link of unmanned Triton Drone, P-8 Poseidon

B

Cogent Communications Q2 2026 Earnings Preview

B

Vital Farms Q2 2026 Earnings Preview

B

Magnera Q3 2026 Earnings Preview

B

Circle outlines $310M-$330M 2026 other revenue, as Arc mainnet targets September 16 launch

S

United Therapeutics anticipates potential 2027 approvals for ralinepag and Tyvaso IPF while holding 2026 revenue outlook unchanged

S

Criteo forecasts 2026 contribution ex-TAC to decline 10% to 12% as it assumes no large-client spending recovery

S

Royalty Pharma targets $3.4B-$3.5B 2026 portfolio receipts as it raises guidance again

S

Champion Homes expects mid-single-digit Q2 revenue growth while excluding Homes Direct

S

Clear outlines Q3 revenue of $284M-$287M while raising FY2026 free cash flow to at least $480M

S

Midday Need to Know: Oil prices ease, CVS beats expectations & more

S

Griffon maintains $1.8B revenue and $458M EBITDA guidance as Australasia JV closes

S

Thomson Reuters declares $0.655 dividend

S

Frontline to sell two VLCCs for $270M

S

Global Payments declares $0.25 dividend

S

Natural Resource Partners declares $0.75 dividend

S

Palmer Square Capital BDC declares $0.36 dividend

S

Apple reportedly rebuffed by CXMT in push for lower memory prices: report

S

Ocugen Q2 2026 Earnings Preview

S

Viatris Q2 preview: Analysts see profits softening amid pressure on generics business

S

Oscar Health Q2 2026 Earnings Preview

S

Quebecor Q2 Earnings Preview

S

Icahn Enterprises declares $0.50 dividend

S

Marcus & Millichap Q2 2026 Earnings Preview

S

Amazon's Zoox will achieve a robotaxi milestone in Las Vegas next week

S

Service Corporation declares $0.36 dividend

S

Galaxy Digital stock slides after unrealized crypto losses still weigh on Q2 results

S